|
Dear AlaskaAngel and Becky - thank you for writing. As it turns out, the option of Taxol/Herceptin only is at DanaFarber and part of that trial that AlaskaAngel mentioned. I saw a doctor here in CA where I live and in Boston (DanaFarber) where my husband's family lives. Looks like we're headed to Boston. The doctor at DanaFarber is in the forefront of breast cancer research (well-published and big reputation and NICE!) and he feels that this is the right combination for me. I asked him about TCH and he said that he didn't like it for me because the T=Taxotere and the C=Carboplatin, both of which he said are really nasty and more than I need. He said that recently research has been questioning the 'C' in the TCH treatment. He thinks the Taxane is what is really critical for Her2. Also, I'm ER and PR+, so I'll do Tamoxifen after chemo too. It seems like this is hitting it hard enough. At least Dr. Harvard thinks so. My doctor here is CA likes the trial but isn't running it so she offered TC or AC + herceptin.
Has anyone else heard statments like this?
PN
|